These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25964850)

  • 1. Evaluating drug-drug interaction information in NDF-RT and DrugBank.
    Peters LB; Bahr N; Bodenreider O
    J Biomed Semantics; 2015; 6():19. PubMed ID: 25964850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a complete dataset of drug-drug interaction information from publicly available sources.
    Ayvaz S; Horn J; Hassanzadeh O; Zhu Q; Stan J; Tatonetti NP; Vilar S; Brochhausen M; Samwald M; Rastegar-Mojarad M; Dumontier M; Boyce RD
    J Biomed Inform; 2015 Jun; 55():206-17. PubMed ID: 25917055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.
    Pathak J; Chute CG
    J Am Med Inform Assoc; 2010; 17(4):432-9. PubMed ID: 20595311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support.
    Fung KW; Kapusnik-Uner J; Cunningham J; Higby-Baker S; Bodenreider O
    J Am Med Inform Assoc; 2017 Jul; 24(4):806-812. PubMed ID: 28339701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling structured product labeling with NDF-RT and RxNorm.
    Zhu Q; Jiang G; Chute CG
    J Biomed Semantics; 2012 Dec; 3(1):16. PubMed ID: 23256517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling Hierarchical View of RxNorm with NDF-RT Drug Classes.
    Palchuk MB; Klumpenaar M; Jatkar T; Zottola RJ; Adams WG; Abend AH
    AMIA Annu Symp Proc; 2010 Nov; 2010():577-81. PubMed ID: 21347044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project.
    Pathak J; Murphy SP; Willaert BN; Kremers HM; Yawn BP; Rocca WA; Chute CG
    AMIA Annu Symp Proc; 2011; 2011():1089-98. PubMed ID: 22195170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-drug Interaction Discovery Using Abstraction Networks for "National Drug File - Reference Terminology" Chemical Ingredients.
    Ochs C; Zheng L; Gu H; Perl Y; Geller J; Kapusnik-Uner J; Zakharchenko A
    AMIA Annu Symp Proc; 2015; 2015():973-82. PubMed ID: 26958234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of standard drug vocabularies in clinical research: a case study in pediatrics.
    Pathak J; Richesson RL
    AMIA Annu Symp Proc; 2010 Nov; 2010():607-11. PubMed ID: 21347050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VA National Drug File Reference Terminology: a cross-institutional content coverage study.
    Brown SH; Elkin PL; Rosenbloom ST; Husser C; Bauer BA; Lincoln MJ; Carter J; Erlbaum M; Tuttle MS
    Stud Health Technol Inform; 2004; 107(Pt 1):477-81. PubMed ID: 15360858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Categorical information in pharmaceutical terminologies.
    Carter JS; Brown SH; Bauer BA; Elkin PL; Erlbaum MS; Froehling DA; Lincoln MJ; Rosenbloom ST; Wahner-Roedler DL; Tuttle MS
    AMIA Annu Symp Proc; 2006; 2006():116-20. PubMed ID: 17238314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning.
    Kastrin A; Ferk P; Leskošek B
    PLoS One; 2018; 13(5):e0196865. PubMed ID: 29738537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning improves prediction of drug-drug and drug-food interactions.
    Ryu JY; Kim HU; Lee SY
    Proc Natl Acad Sci U S A; 2018 May; 115(18):E4304-E4311. PubMed ID: 29666228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of drug-drug interactions by modeling interaction profile fingerprints.
    Vilar S; Uriarte E; Santana L; Tatonetti NP; Friedman C
    PLoS One; 2013; 8(3):e58321. PubMed ID: 23520498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enabling complex queries to drug information sources through functional composition.
    Peters L; Mortensen J; Nguyen T; Bodenreider O
    Stud Health Technol Inform; 2013; 192():692-6. PubMed ID: 23920645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT.
    Winnenburg R; Mortensen JM; Bodenreider O
    J Biomed Semantics; 2015; 6():13. PubMed ID: 25866612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a Clinical Decision Support System for Drug Allergy Management: Are Existing Drug Reference Terminologies Sufficient for Identifying Substitutes and Cross-Reactants?
    Ogallo W; Kanter AS
    Stud Health Technol Inform; 2015; 216():1088. PubMed ID: 26262387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of RxNorm and NDF-RT to normalize and characterize participant-reported medications in an i2b2-based research repository.
    Blach C; Del Fiol G; Dundee C; Frund J; Richesson R; Smerek M; Walden A; Tenenbaum JD
    AMIA Jt Summits Transl Sci Proc; 2014; 2014():35-40. PubMed ID: 25717397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardizing drug adverse event reporting data.
    Wang L; Jiang G; Li D; Liu H
    Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DDI corpus: an annotated corpus with pharmacological substances and drug-drug interactions.
    Herrero-Zazo M; Segura-Bedmar I; Martínez P; Declerck T
    J Biomed Inform; 2013 Oct; 46(5):914-20. PubMed ID: 23906817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.